Informed Consent Form - AIDS and HIV Research Project
Purpose
The participant is aware that the purpose of the AIDS colloidal silver research project is to identify and document the impact of colloidal silver use on the HIV virus and AIDS. The participant is aware that no claims to efficacy are associated with the project.
Procedure
The participant is aware that a 10 PPM isolated colloidal silver (85% ionic, 15% particulate, containing a total of roughly .296 milligrams of silver per ounce ) will be administered orally via one ounce doses according to the following schedule:
One ounce in the morning, daily, for 72 hours.
One ounce taken twice daily for seven days.
One ounce taken four times daily for fourteen days.
One ounce taken eight times daily for three to six months.
The colloidal silver will be held in the mouth for no less than 60 seconds prior to ingestion. Results will be tracked by the co-researching participant and reported to the project coordinator.
Risks and Possible Side Effects
The participant is aware that a herxheimer effect and/or exteriorization of symptoms may occur during the experiment, which may result in additional temporary discomfort but poses no health threat that was not previously present. The participant acknowledges the risk of cosmetic Argyria that may or may not be associated with long term use of isolated colloidal silver.
Confidentiality
The participant's personal details shall be held in strict confidence. The participant hereby releases all data gathered to be used publicly as a part of the study at the discretion of the project manager.
The participant is aware that participation is completely voluntary and that he or she may withdraw from the project at any time without consequence.
Sponsorship of Research
The participant is aware that the research is being conducted as a non-scientific privately sponsored statistical study conducted by The Alternative Visions Research Association, a non-entity located in Las Vegas, Nevada, being performed for journalistic purposes for The Colloidal Silver Database Research Project. The coordinating manager and principle interest is Jason R. Eaton, who may be contacted at 702.839.2185 ( silverdata@hotmail.com ). The participant is aware that he or she is joining as a co-researcher, and will receive no medical treatment, diagnosis, or prognosis of any condition by any agent associated with the project.
Alternate Treatments during the Research Project
The participant is aware that no limitations are imposed by the project with respect to alternate treatments and that the participant is encouraged to pursue therapies suggested by his or her licensed doctor, at the sole discretion of the participant and his or her doctor.
Possible Benefits
The participant is aware that he or she may or may not experience
a reduction in viral loads, increased T-cell counts, reduction of symptoms
associated with the AIDS illness, and improved immune system performance.